^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    veledimex (INXN-1001)

    i
    Associations
    News

    Trials

    Company:
    University of Pennsylvania
    Drug class:
    Immunostimulant
    Related drugs:
    Associations
    News

    Trials

    Apply
    Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102 (NCT03679754)
    Phase 1
    Alaunos Therapeutics
    Completed
    Last update posted :
    09/22/2021
    Initiation :
    09/05/2018
    Primary completion :
    04/02/2019
    Completion :
    01/19/2021
    CD8 • IFNG • CD4
    |
    Ad-RTS-hIL-12 • veledimex (INXN-1001)